ReviewJournal of cellular and molecular medicine2009

Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1.

Ayalew TefferiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.